Researchers from the University of Missouri School of Medicine and the Massachusetts Institute of Technology (MIT) recently evaluated the accuracy of an MIT-developed technology to monitor blood glucose levels without needles or a finger prick
Green JB, Bethel MA, Armstrong PW, Buse JB, Engel SS, Garg J, Josse R, Kaufman KD, Koglin J, Korn S, Lachin JM, McGuire DK, Pencina MJ, Standl E, Stein PP, Suryawanshi S, Van de Werf F, Peterson ED, Holman RR
It is important to note that this concern is entirely theoretical -- no oncological adverse effects have been reported in the limited preclinical studies -- but the biological plausibility is high enough to warrant serious consideration
On paper, the mechanisms appear additive: AOD-9604 targets fat cell lipolysis directly, while GLP-1R agonism targets the energy intake side